Hepatocellular carcinoma occurring in a crohn's disease patient

World Journal of Gastroenterology

Volumn 16, Issue 25, 2010, Pages 3215-3218

  Ishida, Mitsuaki ^a   Naka, Shigeyuki ^a   Shiomi, Hisanori ^a   Tsujikawa, Tomoyuki ^a   Andoh, Akira ^a   Nakahara, Tamio ^a   Saito, Yasuharu ^a   Kurumi, Yoshimasa ^a   Takikita Suzuki, Mikiko ^a   Kojima, Fumiyoshi ^a   Hotta, Machiko ^a   Tani, Tohru ^a   Fujiyama, Yoshihide ^a   Okabe, Hidetoshi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Azathioprine; Crohn's disease; Focal hepatocyte glycogenosis; Hepatocarcinogenesis; Hepatocellular carcinoma

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; CASE REPORT; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; CROHN DISEASE; GLYCOGEN SYNTHESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CARCINOMA; LIVER CELL CARCINOMA; MALE; PRECANCER; REVIEW; CARCINOMA, HEPATOCELLULAR; CHEMICALLY INDUCED; LIVER NEOPLASMS; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AZATHIOPRINE; CARCINOMA, HEPATOCELLULAR; CROHN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; MALE; TREATMENT OUTCOME;

EID: 77954355671     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i25.3215     Document Type: Review

References (18)

1. Juillerat P, Mottet C, Pittet V, Froehlich F, Felley C, Gonvers JJ, Vader JP, Michetti P. Extraintestinal manifestations of Crohn's disease. Digestion 2007; 76: 141-148
2. von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007; 50: 839-855
3. Lee FL, Murray SM, Prior J, Shreeve DR. Primary liver cell cancer occurring in association with Crohn's disease treated with prednisolone and azathioprine. Hepatogastroenterology 1983; 30: 188
4. Cattan S, Wendum D, Chazouilleres O, Schmitz J, Gendre JP. Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy. Hum Pathol 2000; 31: 874-876
5. Borum ML. Unusual development of hepatocellular carcinoma in a patient with Crohn's disease. Dig Dis Sci 2001; 46: 2199-2200
6. Oya H, Sato Y, Yamamoto S, Takeishi T, Kobayashi T, Hatakeyama K. Living related donor liver transplantation for primary sclerosing cholangitis with hepatocellular carcinoma and Crohn's disease: a case report. Transplant Proc 2004; 36: 2297-2298
7. Chen SC, Cummings OW, Hartley MP, Filomena CA, Cho WK. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab. Dig Dis Sci 2006; 51: 952-955
8. Demarchi B, Bresso F, Novero D, Palestro G, Sapone N, Pellicano R, Bonardi R, Smedile A, Rizzetto M, Astegiano M. Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report. Minerva Gastroenterol Dietol 2007; 53: 279-283
9. Samarasena J, Borgaonkar M. Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine. Dig Dis Sci 2007; 52: 2748-2750
10. Miura H, Kawaguchi T, Takazoe M, Kitamura S, Yamada H. Hepatocellular carcinoma and Crohn's disease: a case report and review. Intern Med 2009; 48: 815-819
11. Murakami A, Tanaka Y, Ueda M, Nagano Y, Kunisaki R, Morimoto M, Enaka M, Tanabe M, Kawachi K, Sasaki T, Nozawa A. Hepatocellular carcinoma occurring in a young Crohn's disease patient. Pathol Int 2009; 59: 492-496
12. Etchevers MJ, Aceituno M, Sans M. Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease. World J Gastroenterol 2008; 14: 5512-5518
13. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005; 54: 1121-1125
14. Ingvar A, Smedby KE, Lindelöf B, Fernberg P, Bellocco R, Tufveson G, Höglund P, Adami J. Immunosuppressive treatment after solid organ transplantation and risk of posttransplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant 2009; Epub ahead of print
15. Gruber S, Dehner LP, Simmons RL. De novo hepatocellular carcinoma without chronic liver disease but with 17 years of azathioprine immunosuppression. Transplantation 1987; 43: 597-600
16. Russmann S, Zimmermann A, Krähenbühl S, Kern B, Reichen J. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol 2001; 13: 287-290
17. Arber N, Zajicek G, Nordenberg J, Sidi Y. Azathioprine treatment increases hepatocyte turnover. Gastroenterology 1991; 101: 1083-1086
18. Terasaki S, Kaneko S, Kobayashi K, Nonomura A, Nakanuma Y. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 1998; 115: 1216-1222